<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="reprint-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JRD</journal-id>
      <journal-title-group>
        <journal-title>Journal of Respiratory Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2642-9241</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.14302/issn.2642-9241.jrd-22-4132</article-id>
      <article-id pub-id-type="publisher-id">JRD-22-4132</article-id>
      <article-categories>
        <subj-group>
          <subject>reprint-article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Two-Phase Lung Damage Mechanisms For COVID-19 Disease, and Driving Force and Selectivity in Leukecyte Recruitment and Migration</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jianqing</surname>
            <given-names>Wu</given-names>
          </name>
          <xref ref-type="aff" rid="idm1844969612">1</xref>
          <xref ref-type="aff" rid="idm1844967380">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ping</surname>
            <given-names>Zha</given-names>
          </name>
          <xref ref-type="aff" rid="idm1844968172">2</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1844969612">
        <label>1</label>
        <addr-line>Healthier World (Independent researcher for cause), P. O. Box 689, Beltsville, MD 20704. USA</addr-line>
      </aff>
      <aff id="idm1844968172">
        <label>2</label>
        <addr-line>Independent Researcher</addr-line>
      </aff>
      <aff id="idm1844967380">
        <label>*</label>
        <addr-line>Corresponding author </addr-line>
      </aff>
      <author-notes>
        <corresp>
    
    Jianqing Wu, <addr-line>Healthier World (Independent             researcher for cause), P. O. Box 689, Beltsville, MD 20704. USA</addr-line><email>tempaddr2@atozpatent.com</email></corresp>
        <fn fn-type="conflict" id="idm1844690580">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2022-03-24">
        <day>24</day>
        <month>03</month>
        <year>2022</year>
      </pub-date>
      <volume>1</volume>
      <issue>2</issue>
      <fpage>16</fpage>
      <lpage>27</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>03</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>03</month>
          <year>2022</year>
        </date>
        <date date-type="online">
          <day>24</day>
          <month>03</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© </copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Jianqing Wu, et al.</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/jrd/article/1805">This article is available from http://openaccesspub.org/jrd/article/1805</self-uri>
      <abstract>
        <p>To understand lung damages caused by COVID-19, we deduced two phases lung damage mechanisms. After the lungs are  infected  with  COVID-19,  the affected lung tissue swells and             surface properties  of  pulmonary  capillaries change, both contributing to an increased flow               resistance of the capillaries. The initial damages are mainly fluid leakage in a limited number of involved alveoli.</p>
        <p>The increased vascular resistance results in retaining more white blood cells (“WBCs”) in               pulmonary capillaries. Some of the WBCs may get into interstitial spaces. When more and more WBCs are dynamically retained, the vascular resistance of pulmonary capillaries further rises; and thus the overall vascular resistance of the lungs rises and            pulmonary pressure rises. The rise in the pulmonary pressure in turn results in elevated capillary                  pressures. When pulmonary capillary pressures around the alveoli are  sufficiently  high,  the elevated pressure causes interstitial pressures to change from normally negative values to positive values. The      positive pressures cause fluid leakage to the alvoeli and thus degrade lung function. Tissue swelling, and occupation of WBCs in interstitial spaces and                  occupation of alvoelar spaces by leaked water result in reduced deformable and compressible spaces, and thus causes a further rise of the vascular resistance of the lungs. When the pulmonary pressure has reached a critical point as in the second phase, the  blood  breaks  capillary  walls  and squeezes through                interstitial spaces to reach alveolar spaces, resulting in irreversible lung damages. Among potential               influencing factors, the available space in the thorax cage, temperature, and humid are expected to have great impacts. The free space in the thorax cage, lung usable capacity, and other organ usable capacities are the major factors that determine the arrival time  of                last- phase irreversible damage. The mechanisms imply that the top priority for protecting lungs is                  maintaining pulmonary micro-circulation and preserving organ functions in the entire disease course while                   controlling viral reproduction should be stressed in the earliest time possible. The mechanisms also explain how leukecytes are “recruited and migrated” into inflamed tissues by dynamic retention.</p>
      </abstract>
      <kwd-group>
        <kwd>Coronavirus COVID-19</kwd>
        <kwd>lung damage mechanisms</kwd>
        <kwd>leukecyte recruitment</kwd>
        <kwd>temperature and humidity</kwd>
        <kwd>cold flu influenza</kwd>
        <kwd>interstitial pressure change</kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="2"/>
        <page-count count="12"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1844833708" sec-type="intro">
      <title>Introduction</title>
      <p>The pathological features of lung damages caused by SARS has  been described <xref ref-type="bibr" rid="ridm1842639284">1</xref>. The lungs were                    edematous and increased in weight with extensive                consolidation. The damages include  extensive  edema,  glossy  membrane formation, collapse of alveoli, scaling of alveolar epithelial cells, and fibrous tissue in alveolar spaces. The pathological features of damaged lungs of  COVID-19 patients have been reported <xref ref-type="bibr" rid="ridm1842641372">2</xref>. The patient died from a sudden cardiac arrest.</p>
      <p>The lungs showed bilateral diffuse alveolar             damage with cellular fibromyxoid exudates. The left lung tissue displayed pulmonary oedema with hyaline               membrane formation. Interstitial mononuclear                     inflammatory infiltrates, dominated by lymphocytes, were seen in both lungs. To find best treatments for the                COVID- 19 disease, it is essential to understand the              mechanisms by which the lungs are damaged by the COVID-19 virus. Yoo et al. have conducted a review on viral infection of lungs and host innate and adaptive                responses <xref ref-type="bibr" rid="ridm1842652468">3</xref>. In  that  review,  they discussed more than twenty types of immune and other cells and their functions in initiation, resolution and restoration phases. Exact functions of many of immune cells were unknown. We are interested in finding lung damage mechanisms that would enable health care givers to understand how the lungs are damaged and what factors control the course of lung            damages. Since our purpose is for exploring factors that determine lung damages, we will not include the great details that were known. Existing knowledge could be  incorporated into our proposed mechanisms.</p>
    </sec>
    <sec id="idm1844834068" sec-type="methods">
      <title>Methods</title>
      <p>In this theoretical study, we found and used well known data related to the COVID- 19 diseases, lung           structure, lung physiology, physiological data, blood composition, viral replication, physical factors, environmental factors, etc to predict micro-circulation condition in lungs, change in blood pressure, and changes in lung and other organs. We conducted several simulations to see how the retention of WBCs at various rates can take up free                   deformable and compressible volume in the thorax cage. Our suspect is that when the free space is occupied by leaked blood fluid and exudates, the vascular resistance in lungs rapidly goes up and results in heart arrest or                irreversible damages to the lungs.</p>
      <p>We then propose two-phase mechanisms and use the mechanisms to predict how each of those well known factors affect the course of lung damages.</p>
    </sec>
    <sec id="idm1844832556" sec-type="results">
      <title>Results</title>
      <sec id="idm1844832340">
        <title>Two-Phase Lung Damage Mechanisms</title>
        <p>White blood cells (“WBCs”) pass through                 pulmonary capillaries by deforming themselves and squeezing through <xref ref-type="bibr" rid="ridm1842495476">4</xref>. There is a great size discrepancy between the mean diameter of circulating leukocytes (6-8 µm) and that of the pulmonary capillaries (~5.5 µm). Small lymphocytes are 7 to 10 µm in diameter, and large lymphocytes are approximately 14 to 20 µm in diameter.</p>
      </sec>
      <sec id="idm1844834284">
        <title>Inflammation-Driven Progressive Lung Damage Process</title>
        <p>The endothelium actively participates in                     controlling blood flow, and affect permeability, leukocyte infiltration, and tissue edema <xref ref-type="bibr" rid="ridm1842495476">4</xref><xref ref-type="bibr" rid="ridm1842500156">5</xref><xref ref-type="bibr" rid="ridm1842497132">6</xref>. The changes in         epithelial cells disrupt blood homeostasis by increasing capillaries’ vascular resistance. Other changes include flow  dysregulation, thrombosis, and capillary leaks <xref ref-type="bibr" rid="ridm1842500156">5</xref>. The origin and differentiation cues for many tissue                    macrophages, monocytes, and dendritic cell subsets            remain unclear <xref ref-type="bibr" rid="ridm1842478740">7</xref>. The finding of retention of leukocytes provides several hints. All white blood cells are produced and derived from multipotent cells in the bone marrow known as hematopoietic stem cells. As long as leukocyte concentration in blood can be detected at certain level, a considerable part of them are predicted to enter the lung tissue and exit from the lung tissue except those that die. We can deduce that the cell retention time depends on not only the hole diameters of capillaries but also the elasticity of the capillaries. Second, it is obvious that the                        micro-vascular network of capillaries can be blocked by an excessive number of retained of WBCs. Finally, blood           viscosity must be an important influencing factor. Thus, all factors that affect the blood viscosity affect vascular            resistance and the pulmonary blood pressure.</p>
        <p><xref ref-type="fig" rid="idm1850891564">Figure 1</xref> shows how the retention of WBCs is          responsible for damages to the lungs.</p>
        <fig id="idm1850891564">
          <label>Figure 1.</label>
          <caption>
            <title> The figure shows how large WBCs are retained dynamically when they are moving through pulmonary capillaries </title>
          </caption>
          <graphic xlink:href="images/image1.jpg" mime-subtype="jpg"/>
        </fig>
        <p>Diagram (a) in <xref ref-type="fig" rid="idm1850891564">Figure 1</xref> shows how WBCs squeeze through capillary network with much smaller pores.               Diagram (b) shows that when the tissue is in                               inflammation, the walls of capillaries are changed and the occupation of WBCs in the interstitial spaces will                 generate normal force against the walls of  capillaries, and thus raise friction against the moving of WBCs. Some large WBCs are retained and thus result in higher local capillary pressure. Initially, water leaks out from a limited number of blood vessels and passes through interstitial spaces to reach the space of nearby alveolus. When local blood    pressure rises further to pass a threshold that most            capillaries walls can withstand, as in the second phase, the circulating blood forces WBCs to break through capillaries walls and squeeze through the space between epithelial cells to reach the spaces of the alveolus.</p>
        <p>Early phase Infection leads to swelling and  changes in epithelial cells, which in turn raise the vascular resistance of pulmonary capillaries, raise local capillary pressures and increase interstitial pressures. Normal           capillary pressure at a middle point is about 7 mm Hg. If the capillary is blocked in the venous side, the pressure is same as the arterial pressure (about 15 mm Hg mean). This results in an increase in the interstitial pressure. The reversal of the interstitial pressure leads to fluid leakage to the alveoli, and, if the capillary pressure is too high, the blood raptures epithelium of alveoli and reach alveoli            inner spaces in a limited number of alveoli. In the early phase, lung injury is caused by damages to a limited number of alveoli as sporadic incidences.</p>
        <p>Lungs are a highly expandable and deformable organ. A healthy adult can have 3000 ml inspiration              volume while the normal breathing takes about only 500 ml volume <xref ref-type="bibr" rid="ridm1842481836">8</xref>. This implies that lungs have about 2500 ml extra deformable and compressible space. The air in lungs is compressible, and even the blood is also “compressible” because some of the blood can be squeezed out during compression. If blood flow meets higher flow resistance, the lungs would be less compressible. The lungs are also deformable because the lungs could be deformed to               occupy any part of the free space in the thorax cage.  Moreover, during breath, the lungs can periodically              occupy the space generated by downward moving of the diapharam. When a person does the maximum inspiration, the force drives a considerable amount of blood out of the lungs.</p>
        <p>However, if the blood circulation is partially or             severely jammed, both water and blood cells are nearly non-compressible. Thus, leaked blood reduces available space for capillaries to expand, and has an equivalent           effect of reducing capillary deformability or elasticity.  Affected tissue has an increased vascular resistance to blood circulation, which further promotes the retention of WBCs at higher rates.</p>
        <p>If the inflammation is of a limited degree, the slower traveling speed of WBCs has an effect of extending the WBCs’ dwell times  so that  they can have more time to contact infected cells and foreign matters. However, on a long term basis, the body must maintain balance that the number of entering WBCs must substantially be equal to the number of exiting WBCs. We refer this requirement as WBCs transport balance for convenience. This balance is absolutely vital and determine lungs health and the host person’s life.</p>
        <p>COVID-19 infection or other lungs infection               disturbs the normal WBCs transport balance. As a result, some WBCs may stay in the capillary for too long while certain large WBCs may being caught indefinitely. The infected tissue keeps retaining WBCs. By perpetual                  accumulative effects, the occupation of WBCs in interstitial spaces and slow-travel of WBCs in capillary pores result in higher vascular resistance. The retention of WBCs results in a reduction of WBC concentration in blood. A reduction of the WBCs concentration in the blood causes bone              marrows to generate more WBCs <xref ref-type="bibr" rid="ridm1842652468">3</xref><xref ref-type="bibr" rid="ridm1842500156">5</xref>.</p>
        <p>When newly arrived WBCs travel through the lungs, they are again caught and retained dynamically. Eventually, accumulated WBCs occupy too much of              interstitial spaces, and leaked fluid and blood exudates fill more alveolar spaces. The pulmonary vascular resistance reaches the maximum and shuts down pulmonary                     circulation as heart arrest or multiple organs failure. The most obvious damages are found on alveoli. Alveoli are filled with viscous materials and WBCs <xref ref-type="bibr" rid="ridm1842641372">2</xref><xref ref-type="bibr" rid="ridm1842652468">3</xref>.</p>
        <p>Healthy lungs are highly elastic and have ample room for alveoli and capillaries to expand during               breathing cycles. While the WBCs are accumulated in             interstitial spaces and alveolar air spaces, blood                         circulation in affected locations becomes worse and worse. In the affected locations, normal blood circulation is increasingly replaced by extremely-slow diffusion             process. As a result, some lung cells die from lack of               energy and oxygen. To replace dead tissues, lungs generate fibroblastic cells.</p>
        <p>The total volume of compressible alveolar spaces is estimated to be 2000- 3000 mL. Since part of this               compressible space is attributed to reduced lung blood volume, we use 2000 ml. The heart of an adult person pumps blood at 5 liters per min, The pulmonary flow is essentially same as the cardiac output. WBCs make up                  approximately 1% of the total blood volume. Assuming  that only 0.1%of the WBCs are retained for any time           increment, the retention rate would be equivalent to 0.05 ml volume of WBCs per minute. The retention of WBCs in  interstitial spaces has the same effect of reducing the              volume of alveolar spaces because the total volume of the lungs is substantially fixed. The fluid in alvoelar spaces is not compressible. Free volume occupied by retained WBCs  are shown in <xref ref-type="table" rid="idm1850870828">Table 1</xref>.</p>
        <p>The filled volume can also be estimated by computing the WBC volume. In a normal adult, there are 4.3-10.8 ⨯10(9) WBCs per liter of blood. Assuming 0.1% of the largest WBCs are retained in any given time, we got a similar trend (<xref ref-type="table" rid="idm1850816428">Table 2</xref>).</p>
        <table-wrap id="idm1850870828">
          <label>Table 1.</label>
          <caption>
            <title> Percent of Lung Compressible Space Token By Blood Exudate Increases with Time (Based on 0.1% WBCs retention volume)</title>
          </caption>
          <table rules="all" frame="box">
            <tbody>
              <tr>
                <td>Retention Vol rate.(ml/min)</td>
                <td>Time (min)</td>
                <td>Time (various)</td>
                <td>Exudate Vol. (ml)</td>
                <td>Percent of CompressibleVol. (%)</td>
              </tr>
              <tr>
                <td>0.05</td>
                <td>1</td>
                <td>1 min</td>
                <td>0.05</td>
                <td>0.0025</td>
              </tr>
              <tr>
                <td>0.05</td>
                <td>60</td>
                <td>1 hour</td>
                <td>3</td>
                <td>0.15</td>
              </tr>
              <tr>
                <td>0.05</td>
                <td>1440</td>
                <td>1 day</td>
                <td>72</td>
                <td>3.6</td>
              </tr>
              <tr>
                <td>0.05</td>
                <td>7200</td>
                <td>5 days</td>
                <td>360</td>
                <td>18</td>
              </tr>
              <tr>
                <td>0.05</td>
                <td>14400</td>
                <td>10 days</td>
                <td>720</td>
                <td>36</td>
              </tr>
              <tr>
                <td>0.05</td>
                <td>28800</td>
                <td>20 days</td>
                <td>1440</td>
                <td>72</td>
              </tr>
              <tr>
                <td>0.05</td>
                <td>43200</td>
                <td>30 days</td>
                <td>2160</td>
                <td>Over-limited</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="idm1844770412">
              <label/>
              <p>Lung compressible volume: 2000 ml; blood flow rate: 5 liter/min; WBC: 1% of blood volume; and WBCs retention rate: 0.1%.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="idm1850816428">
          <label>Table 2.</label>
          <caption>
            <title> Percent of Lung Compressible Space Taken By Blood Exudate Increases with Time (based on WBC cell volume)</title>
          </caption>
          <table rules="all" frame="box">
            <tbody>
              <tr>
                <td>WBC No</td>
                <td>Each Cell Vol.(cu.µm)</td>
                <td>Vol. Retention Rate (mL/min)</td>
                <td>Time (min)</td>
                <td>Time (various)</td>
                <td>Exudate Vol. (ml)</td>
                <td>Percent of Lung         Compressible  Vol. (%) </td>
              </tr>
              <tr>
                <td>4E+07</td>
                <td>1000</td>
                <td>0.035</td>
                <td>1</td>
                <td>1 min</td>
                <td>0.035</td>
                <td>0.0018</td>
              </tr>
              <tr>
                <td>4E+07</td>
                <td>1000</td>
                <td>0.035</td>
                <td>60</td>
                <td>1 hour</td>
                <td>2.1</td>
                <td>0.105</td>
              </tr>
              <tr>
                <td>4E+07</td>
                <td>1000</td>
                <td>0.035</td>
                <td>1440</td>
                <td>1 day</td>
                <td>50.4</td>
                <td>2.52</td>
              </tr>
              <tr>
                <td>4E+07</td>
                <td>1000</td>
                <td>0.035</td>
                <td>7200</td>
                <td>5 days</td>
                <td>252</td>
                <td>12.6</td>
              </tr>
              <tr>
                <td>4E+07</td>
                <td>1000</td>
                <td>0.035</td>
                <td>14400</td>
                <td>10 days</td>
                <td>504</td>
                <td>25.2</td>
              </tr>
              <tr>
                <td>4E+07</td>
                <td>1000</td>
                <td>0.035</td>
                <td>28800</td>
                <td>20 days</td>
                <td>1008</td>
                <td>50.4</td>
              </tr>
              <tr>
                <td>4E+07</td>
                <td>1000</td>
                <td>0.035</td>
                <td>43200</td>
                <td>30 days</td>
                <td>1512</td>
                <td>75.6</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The discrepancy between the two methods may be attributed to the approximate volume of WBC cells and estimated mean WBC cell volume. The exact numbers are not important because all of those parameters can vary considerable anyway. What is important is that WBCs  retention is a parameter that can control the lung                  performance and the volume token by retained WBCs can progressively impair the lungs in a time window similar to observed disease time window. In those computations, the lungs have considerable compressible space (for a healthy person). The situation would be much worse for people who even experience shortness of breath in their daily lives.</p>
        <p>When the lungs cannot maintain WBCs transport balance, the lungs may fail within five to ten days. If the retention rate of WBCs increases to 1%, the patient may die in one to two days. This happens when a big part of alveolar spaces are filled by extruded blood and leaked fluid.</p>
      </sec>
      <sec id="idm1844742780">
        <title>Critical Point of Irreversible Lung Damages</title>
        <p>We found there is a critical point for the lungs to experience irreversible damage. The systolic pulmonary pressure is about 25 mm Hg and diastolic pulmonary  pressure is about 8 mm Hg, with the mean pulmonary  arterial pressure being about 15 mm Hg. The negative pressures in interstitial spaces is maintained by the flow caused by lymphatic pumping, and net osmotic pressure.  Extra  fluid that has been on alveoli is sucked back to the lung interstitium through the small openings between   epithelial cells. Damage  to the capillary membrane causes leakage of fluid and plasma proteins and thus result in an increase in the interstitial pressure. The edema of the         interstitium results in a raised interstitial pressure, which can cause immediate rapture of the epithelium.</p>
        <p>When a sufficient number of capillaries are “blocked” by slow-moving or retained WBCs, the overall vascular resistance rises; and slow-moving WBCs in             capillaries reduce the “expandable” volume of the blood vessels in the lungs. An elevated pulmonary pressure in turn raises capillary pressures for all alvoeli. The               interstitial pressures are directly related to capillary            pressures, and become positive when venous pressure is elevated <xref ref-type="bibr" rid="ridm1842481836">8</xref><xref ref-type="bibr" rid="ridm1842473524">9</xref>. If the capillary pressure around an alvoelus is sufficiently high, the outward pressure will be larger than inward pressure. There must be a point at which the pressure at the interstitial space is changed from the        normal negative value  to  a positive  value. It  is  inferred that after a sufficient number of WBCs has been retained, it has a global impact on the lungs. For this reason,                 infection of a sufficient large number of alveoli can cause damages to substantially all alveoli through raising the pulmonary pressure.</p>
      </sec>
      <sec id="idm1844742708">
        <title>Potentially Doubly Exponential Damaging Curve</title>
        <p>In the above computations, we did not consider two self-aggravating factors. We predicted that lung               function degrades potentially by a doubly exponential curve for the following reasons. First, retained WBCs and lung swelling are expected to make pulmonary vascular circulation progressively worse. The expected failure to maintain energy metabolism further aggravates                     inflammation and diminishes the heart ability to maintain required pulmonary vascular circulation. Thus, the speed of lung damage at a later time intervals is faster than that at previous time intervals. Moreover, the lungs have a fixed total volume and all expandable spaces including the “compressible” volume of blood vessels are required for normal breathing. When some compressible spaces are filled by incompressible fluid and WBCs, their adverse impacts cannot be linear. There is a point at which BWCs cannot pass through.</p>
        <p>When more of the lung voids are filled by fluid and WBCs, the pulmonary vascular resistance rises              rapidly. The elevated pulmonary pressure forces blood to squeeze into and through any spaces in the entire lungs. It may take a short time, possibly in a matter of less than an hour to complete the final stage of irreversible damages. When substantially all elastic spaces are occupied by WBCs and fluid, the pulmonary vascular resistance          approaches the maximum, pulmonary flow reaches zero, and lung function approaches zero. There is no way to stop or reverse.</p>
        <p>Considering the potentially doubly exponential damaging process, we estimate that dynamic retention rates of WBCs could be 0.01%-0.1% initially, increase to 0.1% to 1% when the lungs lose most function; the blood rapidly fills the voids in the lungs finally. Our ballpark     prediction is consistent with the rapid disease course from shortness of breath to death <xref ref-type="bibr" rid="ridm1842652468">3</xref>. The  damaging  process implies that the problem is correctable by using right methods only in the earliest time. We cannot over stress the importance of this strategy.</p>
      </sec>
      <sec id="idm1844742060">
        <title>Physiological Injury of Low Temperature to the Lungs</title>
        <p>Low temperature is known to affect flu <xref ref-type="bibr" rid="ridm1842452844">14</xref> and blood vessels <xref ref-type="bibr" rid="ridm1842437292">13</xref>. Low temperature causes capillaries to contract to add more friction to WBCs traveling and cause some WBCs retained indefinitely. Low temperature                promotes fluid leakage to the affected alveolus and              hinders oxygen-carbon dioxide exchange. Reduced               oxygen delivery causes blood vessel vasodilation <xref ref-type="bibr" rid="ridm1842405324">23</xref> and make the situation worse. Low temperature also adversely affects the lungs by influencing blood viscosity. For a           segment of capillary, its vascular resistance can be                  determined by equation R = 8ηl/πr4. Low temperature affects the flow resistance by the viscosity term and the                 radium to the fourth power (r4). This is why exposure to low temperature is the biggest aggravation factor of cold, flu and COVID-19. If a large number of WBCs is in the blood, they raise local vascular resistance. Low temperature might dramatically impact the travel-through of big WBCs. If one or more WBCs are retained in the capillary or move too slowly along the capillary pore, the bulky fluid of blood has to squeeze though the tiny void between the surface of retained WBCs and the capillary wall. Low              temperature can have a big role in causing interstitial pressures to change from negative to positive and blood leakage into the alveoli. Low temperature may cause the critical time of damage to arrive earlier.</p>
        <p>Since the mechanisms tell only how the lungs are damaged reversibly or irreversibly, such mechanisms are not enough for predicting the severity of lung damages or death. Thus, we must focus on lung structures and              personal health. It is well known that a person’s ability to survive depends on their vital functional reserves <xref ref-type="bibr" rid="ridm1842472516">10</xref><xref ref-type="bibr" rid="ridm1842447372">11</xref><xref ref-type="bibr" rid="ridm1842441684">12</xref>. Those functions provide additional useful information about a person’s ability to resolve infection. Many other factors can aggravate damages to alveoli by influencing mobility of WBCs. They include red blood cells count, platelets aggregation degree, and natures and amounts of other macro-molecules because they can affect blood              viscosity. Moreover, chronic stress and emotional distress on disease outcomes <xref ref-type="bibr" rid="ridm1842418852">16</xref><xref ref-type="bibr" rid="ridm1842414100">17</xref><xref ref-type="bibr" rid="ridm1842425260">18</xref><xref ref-type="bibr" rid="ridm1842422884">19</xref><xref ref-type="bibr" rid="ridm1842398700">20</xref><xref ref-type="bibr" rid="ridm1842397764">21</xref><xref ref-type="bibr" rid="ridm1842393660">22</xref> (to be explained  later). Free space in the thorax cage and body mechanic vibrations are two unique factors.</p>
      </sec>
      <sec id="idm1844741988">
        <title>Further Lung Damages Induced by Insufficient Lung                Function</title>
        <p>If the lungs are unable to perform required                functions, expected degraded energy metabolism leads to a diminished lung function and leads to failure of major organs such as heart, kidneys, and liver. Those processes are shown in <xref ref-type="fig" rid="idm1850781028">Figure 2</xref>.</p>
        <fig id="idm1850781028">
          <label>Figure 2.</label>
          <caption>
            <title> It Shows how the virus-triggered WBCs retention can impair          other vital organs such as liver, heart and kidneys, resulting in final heart              failure or multiple organ failure.</title>
          </caption>
          <graphic xlink:href="images/image2.jpg" mime-subtype="jpg"/>
        </fig>
        <p><xref ref-type="fig" rid="idm1850781028">Figure 2</xref> shows how viral infection triggers the retention of WBCs and causes damages to alveoli as               indicated by the round circular diagram. The damages to alveoli results in higher pulmonary vascular resistance and degraded energy metabolism. The degraded energy metabolism  will  impair  heart,  kidneys,  liver, etc. The increased vascular resistance and impaired heart, renal and liver function inevitably result in heart failure                   (as indicated by dashed red arrows).</p>
        <p>The human ability to survive depends on vital   usable functional capacities of heart, kidneys and               liver <xref ref-type="bibr" rid="ridm1842472516">10</xref><xref ref-type="bibr" rid="ridm1842447372">11</xref><xref ref-type="bibr" rid="ridm1842441684">12</xref>. Virus-caused inflammation diminishes lung functions <xref ref-type="bibr" rid="ridm1842652468">3</xref><xref ref-type="bibr" rid="ridm1842495476">4</xref>, and causes the lungs to fail to deliver          required  oxygen  for  the body. The insufficiency of                 oxygen must lead to diminished energy production for the whole body. This is expected to cause heart                          failure <xref ref-type="bibr" rid="ridm1842652468">3</xref><xref ref-type="bibr" rid="ridm1842495476">4</xref> and impair renal function <xref ref-type="bibr" rid="ridm1842357516">24</xref><xref ref-type="bibr" rid="ridm1842352332">25</xref>. The                 impaired renal function in turn adversely affects the             heart <xref ref-type="bibr" rid="ridm1842352332">25</xref><xref ref-type="bibr" rid="ridm1842351828">26</xref> and the lungs <xref ref-type="bibr" rid="ridm1842361908">27</xref><xref ref-type="bibr" rid="ridm1842359172">28</xref>. While only a few             references are cited, we confidently found that                        impairment of any vital organ must finally result in failure of heart or multiple organ failure as long as the                        impairment of the vital organ is sufficiently long. By going through those vicious cycles, the viral infection has an       effect of retaining more WBCs in the tissue, retaining more metabolic wastes, and causing more damages to the lungs, the heart  and  the kidneys. It is possible that some              patients die from organ failure caused by the vicious          cycles even before the lungs have reached the critical point of breaking blood vessels if the patient’s organ                functions in the heart or other vital organs play                determinant roles.</p>
        <p>Severe lung damages could be caused by viral damages before the start of adaptive immune responses. This may happen because low temperature causes blood vessels and capillaries to constrict and raises blood                 viscosity <xref ref-type="bibr" rid="ridm1842437292">13</xref>. The proposed mechanisms can also explain the effect of humidity on the disease <xref ref-type="bibr" rid="ridm1842452844">14</xref>. When air             humidity is high, water molecules coming from alveolar space are not brought out efficiently. The water layers on alveolar walls is expected to interfere with oxygen-carbon dioxide exchange. The mechanisms can explain the role of blood viscosity, mechanical vibrations, etc. Objects jammed at a bottleneck of a bag can be facilitated by           making mechanical vibrations. The mechanisms also           explain why old people are more vulnerable to the           virus. Old people have diminished organ                                      capacities <xref ref-type="bibr" rid="ridm1842472516">10</xref><xref ref-type="bibr" rid="ridm1842447372">11</xref><xref ref-type="bibr" rid="ridm1842441684">12</xref> and their blood vessels are less  elastic. The mechanisms also explain the role of chronic stress and emotional distress on disease                                   outcomes <xref ref-type="bibr" rid="ridm1842418852">16</xref><xref ref-type="bibr" rid="ridm1842414100">17</xref><xref ref-type="bibr" rid="ridm1842425260">18</xref><xref ref-type="bibr" rid="ridm1842422884">19</xref><xref ref-type="bibr" rid="ridm1842398700">20</xref><xref ref-type="bibr" rid="ridm1842397764">21</xref><xref ref-type="bibr" rid="ridm1842393660">22</xref>. When the patient is in a relaxed state, the pulmonary vascular circulation is improved and WBCs encounter less friction.</p>
      </sec>
      <sec id="idm1844739828">
        <title>Driving Force and Selectivity in Leukocyte Recruitment and Migration</title>
        <p>Our proposed lung damage mechanisms add more variables to classic leukocytes recruitment theory. Unlike motility in bacterial chemotaxis, mechanism by which  leukocytes physically move is unclear. T and B cell homing and transendothelial migration have been extensively studied <xref ref-type="bibr" rid="ridm1842341740">29</xref>. How neutrophils get activated in a proper way and degree so that they can adhere to the                      endothelial surface, locomote to right localities and squeeze through small pores is not fully understood <xref ref-type="bibr" rid="ridm1842338932">30</xref>. Further, no directional signals have been found to cause leukocytes to move to the inflammation site <xref ref-type="bibr" rid="ridm1842341740">29</xref>. The             existing leukocyte recruitment theory can explain that an inflamed tissue selectively  retains leukocytes in great  details, but could not explain why blood exudates are found in alevoelar spaces.</p>
        <p>It is believed that leukocytes take the “path of least resistance” across the endothelium <xref ref-type="bibr" rid="ridm1842336772">31</xref>. That means that leukocyte migration path through the intercellular space or through cells may depend on the relative                tightness of the endothelial junctions and the ability of the leukocytes to breach them. Existing theories do not use local blood pressures as the driving force. We found that elevated blood pressure or pressure gradient, and              structural strength in capillaries or interstitial spaces are determining factors.</p>
        <p>Some studies have investigated hydrodynamic properties for leukocytes migration. Models they used involve cancer cell culture media <xref ref-type="bibr" rid="ridm1842333820">32</xref>, adhesive rolling of deformable leukocytes over a coated surface in parabolic shear flow in microchannels <xref ref-type="bibr" rid="ridm1842330364">33</xref> or a simple                             hydrodynamic model <xref ref-type="bibr" rid="ridm1842325108">34</xref>. Those models do not mimic the structures of lungs and do not consider blood pressures in capillary networks in the lungs. One study implies that cell deformability significantly reduces the flow resistance and that high cell concentration must increase the flow            resistance <xref ref-type="bibr" rid="ridm1842330364">33</xref>.</p>
        <p>Erratic and uncontrolled leukocyte migration and accumulation were seen in diseased tissues such as               atherosclerotic plaque  <xref ref-type="bibr" rid="ridm1842323740">35</xref>  and  rheumatoid  arthritic tissue <xref ref-type="bibr" rid="ridm1842319204">36</xref>. Anti-inflammatory drugs have been used to reduce leukocyte recruitment <xref ref-type="bibr" rid="ridm1842315748">37</xref>. Those findings as well as personal observations all show that WBCs are               accumulated on a tissue that is inflamed. The whole body tissue is like a big filter from which the blood passes through, and WBCs pass through the filter in a steady state condition. Whenever any specific part of the tissue is             inflamed, this part of the tissue will selectively retain WBCs by increasing flow friction. This may be intended by the evolution design to increase dwell times for WBCs to perform their functions at the inflamed site. Leukocytes  horizontal migration may be limited to diffusion and their preference to move through the path with the lowest resistance. When blood keeps feeding the WBCs into               tissues, more of the WBCs reach and stay wherever                inflammation has happened. There is no need to recruit WBCs from neighbor tissues in a direction perpendicular to blood flow direction. This may give an impression that WBCs can be recruited in horizontal directions. However, the excessive retention of WBCs becomes a fatal problem if they occupy too much volume in the thorax cage.</p>
      </sec>
      <sec id="idm1844737020">
        <title>Implications of the Lung Damage Mechanisms</title>
        <p>Maintaining pulmonary vascular circulation is the top priority in the entire disease course for COVID-19 as well as other lung infection. Maintaining the mobility of WBCs is vitally important to both innate immunity and acquired immune response <xref ref-type="bibr" rid="ridm1842294900">39</xref><xref ref-type="bibr" rid="ridm1842291012">40</xref><xref ref-type="bibr" rid="ridm1842287484">41</xref>.</p>
        <p>Our mechanisms imply that temperature is very important factor. Temperature may regulate immunity by multiple ways <xref ref-type="bibr" rid="ridm1842284820">42</xref>. Hyperthermic temperatures affect function of all types of cells include DCs, macrophages, NK cells, neutrophils, T and B lymphocytes, and vascular            endothelial cells. High temperatures (42°C for 15 min) has been found to blunt leukocyte adhesion even 2 days after the heat treatment in vivo <xref ref-type="bibr" rid="ridm1842281364">43</xref>. This finding implies that a pre-treatment with warm temperature could mitigate  severity of COVID-19  disease that is caused by a            subsequent exposure. It is believed that fever                          temperatures can broadly promote immune surveillance during challenge by invading pathogens <xref ref-type="bibr" rid="ridm1842284820">42</xref>. Body                 temperature is controlled by substance interleukin-1 (or leukocyte pyrogen) in the hypothalamus of the brain.                 Interleukin-1 is released from blood leukocytes and tissue macrophages that have digested viruses and bacteria <xref ref-type="bibr" rid="ridm1842481836">8</xref>. Raising temperature can improve both  immune functions  and mitigate lung damages caused by immune cell                       congestion.</p>
        <p>Our mechanisms imply that raising body                     temperature can help improve pulmonary                                    micro-circulation and keep WBCs transport balance.               Patients should be advised to avoid exposure to low                  temperature and high humidity in the entire disease course. Other measures should be taken to reduce blood viscosity. We question the measure of using drugs  to               lower  body  temperature  as the  standard of care simply because patients demand comfort. Excessive  fever  can  cause damage to the Central Nervous System. A better strategy is maintaining the body at a higher temperature but lowering the head’s temperature by using a cooling bath only if necessary. If cooling is necessary, it should be used only to the extent to avoid fever damages to the brain, but should never overdo.</p>
        <p>The mechanisms also imply that antiviral drugs or alternative measures should be taken as early as possible. When the virus has infected the whole lungs and the             patient’s lung function has approached a disability level, such a drug treatment may burden the lungs by its side effects. A sound strategy is to reduce tissue                                 inflammation <xref ref-type="bibr" rid="ridm1842315748">37</xref>, reduce vascular resistance, keep waste removal balance and strengthen vital organs.</p>
        <p>The mechanisms imply that age, obesity, and          organ usable functions are the most important factors. Age is related to organ reserve <xref ref-type="bibr" rid="ridm1842472516">10</xref><xref ref-type="bibr" rid="ridm1842447372">11</xref><xref ref-type="bibr" rid="ridm1842441684">12</xref>. However, organ              functional reserve may include functions that are not           presently useful. We  use organ usable function capacity  to  stress  that  functional  capacities  that  are actually          deliverable. When a person’s lungs have little  surplus  capacity,  the infection can more likely cause the lungs to enter the self-degrading cycle. Obesity must be a critical factor because extra fat tissue consumes too much of the free thoracic space. The severity of obesity is indicated by a large size of abdomen. However, extra tissues inside thorax cannot grow out in the thorax cage because all ribs are not deformable. This implies that some extra tissues can only grow within inner thorax cage, and this is why shortness of breathe is a common sign of obesity. Reduced free space in the thorax cage means that an infection can more quickly raise the pulmonary blood pressure, and such a person has much shorter time to resolve the infection  before the lungs get into vicious aggravating stage. In                addition, extra tissues in obese persons necessarily            increase the demand for all vital organ functional               capacities, and reduce body’s ability to clear up metabolic by-products. Like low temperature, obesity adversely           affects the patient’s ability to fight COVID-19 disease in multiple ways. That is why losing extra body weight is the most effective strategy to increase chances to survive from the pandemic.</p>
        <p>Medicine should explore safe drugs that can dilate blood vessels that can be used to relieve WBC retention.</p>
      </sec>
    </sec>
    <sec id="idm1844738172">
      <title>Funding Statement</title>
      <p>The author(s) declared that no grant was used in support of this research project.</p>
    </sec>
    <sec id="idm1844738748">
      <title>Article History</title>
      <p>This subject of this article was initially disclosed in part in preprint.org on 6 February 2020, and was later rewritten and posted in substantially current form on  preprints.org server on 8 September 2020.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ridm1842639284">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Gu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Korteweg</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Pathology and Pathogenesis of Severe Acute Respiratory Syndrome</article-title>
          <date>
            <year>2007</year>
          </date>
          <source>The American Journal of Pathology</source>
          <volume>170</volume>
          <fpage>4</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842641372">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Zhe</surname>
            <given-names>Xu</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine</article-title>
          <date>
            <year>2020</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1842652468">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Yoo</surname>
            <given-names>J-K</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>T S</given-names>
          </name>
          <name>
            <surname>Hufford</surname>
            <given-names>M M</given-names>
          </name>
          <name>
            <surname>Braciale</surname>
            <given-names>T J</given-names>
          </name>
          <article-title>Viral infection of the lung: Host response and sequelae</article-title>
          <source>J Allergy Clin Immunol</source>
          <volume>132</volume>
          <issue>6</issue>
        </mixed-citation>
      </ref>
      <ref id="ridm1842495476">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Downey</surname>
            <given-names>G P</given-names>
          </name>
          <name>
            <surname>Doherty</surname>
            <given-names>D E</given-names>
          </name>
          <name>
            <surname>Schwab</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Retention of leukocytes in capillaries: role of cell size and deformability</article-title>
          <date>
            <year>1990</year>
          </date>
          <source>J Appl Physiol</source>
          <volume>69</volume>
          <fpage>1767</fpage>
          <lpage>1778</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842500156">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Pober</surname>
            <given-names>J S</given-names>
          </name>
          <name>
            <surname>Sessa</surname>
            <given-names>W C</given-names>
          </name>
          <article-title>Inflammation and the Blood Microvascular System. Cold Spring Harb Perspect Biol</article-title>
          <date>
            <year>2015</year>
          </date>
          <volume>7</volume>
          <fpage>016345</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842497132">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Mercer</surname>
            <given-names>B A</given-names>
          </name>
          <name>
            <surname>Lemaître</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Powell</surname>
            <given-names>C A</given-names>
          </name>
          <name>
            <surname>D’Armiento</surname>
            <given-names>J</given-names>
          </name>
          <article-title>The Epithelial Cell in Lung Health and Emphysema Pathogenesis. Curr Respir Med Rev</article-title>
          <date>
            <year>2006</year>
          </date>
          <volume>2</volume>
          <issue>2</issue>
          <fpage>101</fpage>
          <lpage>142</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842478740">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Geissmann</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Manz</surname>
            <given-names>M G</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Development of monocytes, macrophages and dendritic cell. Science</article-title>
          <date>
            <year>2010</year>
          </date>
          <volume>327</volume>
          <issue>5966</issue>
          <fpage>656</fpage>
          <lpage>661</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842481836">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Guyton</surname>
            <given-names>A C</given-names>
          </name>
          <article-title>The cough reflex</article-title>
          <chapter-title>In Text of Medical Physiology (8th Ed). W.B. Saunders Company. pg 411-412 (various</chapter-title>
          <fpage>page rages).</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842473524">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><article-title>Pressure-volume relationships in the interstitial spaces. Investigative Ophthalmology</article-title><date><year>1965</year></date>
Available at iovs.arvojournals.org on 03/01/2020



</mixed-citation>
      </ref>
      <ref id="ridm1842472516">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>WMT</surname>
            <given-names>Bortz</given-names>
          </name>
          <name>
            <surname>Bortz</surname>
            <given-names>W M</given-names>
          </name>
          <article-title>How fast do we age? Exercise performance over time as a biomarker</article-title>
          <date>
            <year>1996</year>
          </date>
          <source>J Gerontol A Biol Sci Med Sci</source>
          <volume>51</volume>
          <fpage>223</fpage>
          <lpage>5</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842447372">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Goldspink</surname>
            <given-names>D F</given-names>
          </name>
          <article-title>Ageing and activity: Their effects on the functional reserve capacities of the heart and vascular smooth and skeletal muscles. Ergonomics</article-title>
          <date>
            <year>2005</year>
          </date>
          <volume>48</volume>
          <fpage>1334</fpage>
          <lpage>51</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842441684">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Sehl</surname>
            <given-names>M E</given-names>
          </name>
          <name>
            <surname>Yates</surname>
            <given-names>F E</given-names>
          </name>
          <article-title>Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people</article-title>
          <date>
            <year>2001</year>
          </date>
          <source>J Gerontol A Biol Sci Med Sci</source>
          <volume>56</volume>
          <issue>1</issue>
          <fpage>98</fpage>
          <lpage>208</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842437292">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Shepherd</surname>
            <given-names>J T</given-names>
          </name>
          <name>
            <surname>Rusch</surname>
            <given-names>N J</given-names>
          </name>
          <name>
            <surname>Vanhoutte</surname>
            <given-names>P M</given-names>
          </name>
          <article-title>Effect of cold on the blood vessel wall. Gen Pharmacol</article-title>
          <date>
            <year>1983</year>
          </date>
          <volume>14</volume>
          <issue>1</issue>
          <fpage>61</fpage>
          <lpage>4</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842452844">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Anice</surname>
            <given-names>C Lowen</given-names>
          </name>
          <name>
            <surname>Steel</surname>
            <given-names>John</given-names>
          </name>
          <article-title>Roles of Humidity and Temperature in Shaping Influenza Seasonality. Journal of Virology</article-title>
          <date>
            <year>2014</year>
          </date>
          <volume>88</volume>
          <issue>14</issue>
          <fpage>7692</fpage>
          <lpage>7695</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842419644">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Hawryluck</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Gold</surname>
            <given-names>W L</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Emerg Infect Dis</article-title>
          <date>
            <year>2004</year>
          </date>
          <chapter-title>SARS Control and Psychological Effects of Quarantine</chapter-title>
          <volume>10</volume>
          <issue>7</issue>
          <fpage>1206</fpage>
          <lpage>12</lpage>
          <publisher-loc>Toronto, Canada</publisher-loc>
        </mixed-citation>
      </ref>
      <ref id="ridm1842418852">
        <label>16.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Steptoe</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hamer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chida</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis</article-title>
          <date>
            <year>2007</year>
          </date>
          <source>Brain Behav Immun</source>
          <volume>21</volume>
          <issue>7</issue>
          <fpage>901</fpage>
          <lpage>12</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842414100">
        <label>17.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Segerstrom</surname>
            <given-names>S C</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>G E</given-names>
          </name>
          <article-title>Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry</article-title>
          <date>
            <year>2004</year>
          </date>
          <source>Psychol Bull</source>
          <volume>130</volume>
          <issue>4</issue>
          <fpage>601</fpage>
          <lpage>30</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842425260">
        <label>18.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Dhabhar</surname>
            <given-names>F S</given-names>
          </name>
          <article-title>Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res</article-title>
          <date>
            <year>2014</year>
          </date>
          <volume>58</volume>
          <issue>3</issue>
          <fpage>193</fpage>
          <lpage>210</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842422884">
        <label>19.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Walburn</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vedhara</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hankins</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Psychological stress and wound healing in humans: a systematic review and meta-analysis</article-title>
          <date>
            <year>2009</year>
          </date>
          <source>J Psychosom Res</source>
          <volume>67</volume>
          <issue>3</issue>
          <fpage>253</fpage>
          <lpage>71</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842398700">
        <label>20.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Webster</surname>
            <given-names>Marketon JI</given-names>
          </name>
          <name>
            <surname>Glaser</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Stress hormones and immune function. Cell Immunol.252(1-2):</article-title>
          <date>
            <year>2008</year>
          </date>
          <fpage>16</fpage>
          <lpage>26</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842397764">
        <label>21.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Pedersen</surname>
            <given-names>A F</given-names>
          </name>
          <name>
            <surname>Zachariae</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bovbjerg</surname>
            <given-names>D H</given-names>
          </name>
          <article-title>Psychological stress and antibody response to influenza vaccination: a meta-analysis. Brain Behav Immun</article-title>
          <date>
            <year>2009</year>
          </date>
          <volume>23</volume>
          <issue>4</issue>
          <fpage>427</fpage>
          <lpage>33</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842393660">
        <label>22.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Pedersen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zachariae</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bovbjerg</surname>
            <given-names>D H</given-names>
          </name>
          <article-title>Influence of psychological stress on up- per respiratory infection—a meta-analysis of prospective studies. Psychosom Med</article-title>
          <date>
            <year>2010</year>
          </date>
          <volume>72</volume>
          <issue>8</issue>
          <fpage>823</fpage>
          <lpage>32</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842405324">
        <label>23.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Michiels</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Physiological and Pathological Responses to Hypoxia</article-title>
          <date>
            <year>2004</year>
          </date>
          <source>The American Journal of Pathology</source>
          <volume>164</volume>
          <issue>6</issue>
          <fpage>1875</fpage>
          <lpage>82</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842357516">
        <label>24.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Chihanga</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ruby</surname>
            <given-names>H N</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>Q</given-names>
          </name>
          <article-title>NMR-based urine metabolic profiling and immunohistochemistry analysis of nephron changes in a mouse model of hypoxia-induced acute kidney injury</article-title>
          <date>
            <year>2018</year>
          </date>
          <source>Am J Physiol Renal Physiol</source>
          <volume>315</volume>
          <issue>4</issue>
          <fpage>1159</fpage>
          <lpage>1173</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842352332">
        <label>25.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>YM1</surname>
            <given-names>Arabi</given-names>
          </name>
          <name>
            <surname>Al-Omari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mandourah</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med</article-title>
          <date>
            <year>2017</year>
          </date>
          <volume>45</volume>
          <issue>10</issue>
          <fpage>1683</fpage>
          <lpage>1695</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842351828">
        <label>26.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Ter</surname>
            <given-names>Maaten JM</given-names>
          </name>
          <name>
            <surname>Damman</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Verhaar</surname>
            <given-names>M C</given-names>
          </name>
          <article-title>Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Eur</source>
          <volume>18</volume>
          <issue>6</issue>
          <fpage>588</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.1002/ejhf.497</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842361908">
        <label>27.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Visconti</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Santoro</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cernaro</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Kidney-lung connections in acute and chronic diseases: current perspectives. J Nephrol</article-title>
          <date>
            <year>2016</year>
          </date>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>341</fpage>
          <lpage>348</lpage>
          <pub-id pub-id-type="doi">10.1007/s40620-016-0276-7</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842359172">
        <label>28.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Domenech</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Perez</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Saldarini</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Kidney-lung pathophysiological crosstalk: its characteristics and importance. Int Urol Nephrol</article-title>
          <date>
            <year>2017</year>
          </date>
          <volume>49</volume>
          <issue>7</issue>
          <fpage>1211</fpage>
          <lpage>1215</lpage>
          <pub-id pub-id-type="doi">10.1007/s11255-017-1585-z</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842341740">
        <label>29.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Muller</surname>
            <given-names>W A</given-names>
          </name>
          <article-title>Transendothelial Migration: Unifying Principles from the Endothelial Perspective. Immunol Rev</article-title>
          <date>
            <year>2016</year>
          </date>
          <volume>273</volume>
          <issue>1</issue>
          <fpage>61</fpage>
          <lpage>75</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842338932">
        <label>30.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Heemskerk</surname>
            <given-names>N</given-names>
          </name>
          <article-title>F-actin-rich contractile endothelial pores prevent vascular leakage during leukocyte diapedesis through local RhoA signalling</article-title>
          <date>
            <year>2016</year>
          </date>
          <source>Nat Commun</source>
          <volume>7</volume>
          <fpage>10493</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842336772">
        <label>31.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Carman</surname>
            <given-names>C V</given-names>
          </name>
          <name>
            <surname>Springer</surname>
            <given-names>T A</given-names>
          </name>
          <article-title>Trans-cellular migration: cell-cell contacts get intimate</article-title>
          <date>
            <year>2008</year>
          </date>
          <source>Curr Opin Cell Biol</source>
          <volume>20</volume>
          <fpage>533</fpage>
          <lpage>540</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842333820">
        <label>32.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>NNO</surname>
            <given-names>Ngalame</given-names>
          </name>
          <name>
            <surname>Luz</surname>
            <given-names>A L</given-names>
          </name>
          <name>
            <surname>Makia</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tokar</surname>
            <given-names>E J</given-names>
          </name>
          <article-title>Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype. Toxicological Sciences</article-title>
          <date>
            <year>2018</year>
          </date>
          <volume>165</volume>
          <issue>1</issue>
          <fpage>40</fpage>
          <lpage>49</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842330364">
        <label>33.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Pappu</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Doddi</surname>
            <given-names>S K</given-names>
          </name>
          <name>
            <surname>Bagchi</surname>
            <given-names>P</given-names>
          </name>
          <article-title>A computational study of leukocyte adhesion and its effect on flow pattern in microvessels. J Theor Biol</article-title>
          <date>
            <year>2008</year>
          </date>
          <volume>254</volume>
          <issue>2</issue>
          <fpage>483</fpage>
          <lpage>98</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842325108">
        <label>34.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Subramaniam</surname>
            <given-names>D R</given-names>
          </name>
          <name>
            <surname>Gee</surname>
            <given-names>D J</given-names>
          </name>
          <article-title>The influence of adherent cell morphology on hydrodynamic recruitment of leukocytes</article-title>
          <date>
            <year>2018</year>
          </date>
          <source>Microvasc Res</source>
          <volume>115</volume>
          <fpage>68</fpage>
          <lpage>74</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842323740">
        <label>35.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ley</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Lymphocyte migration into atherosclerotic plaque. Arteriosclerosis, Thrombosis, and Vascular Biology</article-title>
          <date>
            <year/>
          </date>
          <volume>35</volume>
          <issue>1</issue>
          <fpage>40</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1161/ATVBAHA.114.303227</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842319204">
        <label>36.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Rana</surname>
            <given-names>A K</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>F</given-names>
          </name>
          <article-title>Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis</article-title>
          <date>
            <year>2018</year>
          </date>
          <source>International Immunopharmacology</source>
          <volume>65</volume>
          <fpage>348</fpage>
          <lpage>359</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842315748">
        <label>37.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Planagumà</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Domènech</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pont</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation</article-title>
          <date>
            <year>2015</year>
          </date>
          <source>Pulmonary Pharmacology &amp; Therapeutics</source>
          <volume>34</volume>
          <fpage>37</fpage>
          <lpage>45</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842297492">
        <label>38.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Westphalen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gusarova</surname>
            <given-names>G A</given-names>
          </name>
          <name>
            <surname>Islam</surname>
            <given-names>M N</given-names>
          </name>
          <article-title>Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity</article-title>
          <source>Nature</source>
          <volume>506</volume>
          <issue>7489</issue>
          <fpage>503</fpage>
          <lpage>6</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842294900">
        <label>39.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Kirby</surname>
            <given-names>A C</given-names>
          </name>
          <name>
            <surname>Coles</surname>
            <given-names>M C</given-names>
          </name>
          <name>
            <surname>Kaye</surname>
            <given-names>P M</given-names>
          </name>
          <article-title>2009;Alveolar macrophages transport pathogens to lung draining lymph nodes</article-title>
          <source>J Immunol</source>
          <volume>183</volume>
          <issue>3</issue>
          <fpage>1983</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842291012">
        <label>40.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Bhattacharya</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Westphalen</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Macrophage-epithelial interactions in pulmonary alveoli. Semin Immunopathol</article-title>
          <date>
            <year>2016</year>
          </date>
          <volume>38</volume>
          <issue>4</issue>
          <fpage>461</fpage>
          <lpage>469</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842287484">
        <label>41.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Rodero</surname>
            <given-names>M P</given-names>
          </name>
          <name>
            <surname>Poupel</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Loyher</surname>
            <given-names>P-L</given-names>
          </name>
          <article-title>Immune surveillance of the lung by migrating tissue monocytes. eLife 4:</article-title>
          <date>
            <year>2015</year>
          </date>
          <fpage>07847</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1842284820">
        <label>42.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Evans</surname>
            <given-names>S S</given-names>
          </name>
          <name>
            <surname>Repasky</surname>
            <given-names>E A</given-names>
          </name>
          <name>
            <surname>Fisher</surname>
            <given-names>D T</given-names>
          </name>
          <article-title>Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol</article-title>
          <date>
            <year>2015</year>
          </date>
          <volume>15</volume>
          <issue>6</issue>
          <fpage>335</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="doi">10.1038/nri3843</pub-id>
        </mixed-citation>
      </ref>
      <ref id="ridm1842281364">
        <label>43.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>House</surname>
            <given-names>S D</given-names>
          </name>
          <name>
            <surname>Guidon</surname>
            <given-names>Jr PT</given-names>
          </name>
          <name>
            <surname>Perdrizet</surname>
            <given-names>G A</given-names>
          </name>
          <article-title>Effects of heat shock, stannous chloride, and gallium nitrate on the rat inflammatory response. Cell Stress Chaperones</article-title>
          <date>
            <year>2001</year>
          </date>
          <volume>6</volume>
          <fpage>164</fpage>
          <lpage>171</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
